Literature DB >> 21850542

An essential role of PDCD4 in progression and malignant proliferation of gastrointestinal stromal tumors.

Lingling Ding1, Xia Zhang, Miaoqing Zhao, Zhonghua Qu, Shanying Huang, Mei Dong, Fei Gao.   

Abstract

Programmed cell death 4 (PDCD4) is a tumor suppressor that can inhibit tumorigenesis by suppressing activator protein (AP)-1 activation and protein translation. Lost or decreased PDCD4 expression has been found in multiple types of human cancers, which was also associated with progression and metastasis of the tumors. However, the status and significance of PDCD4 in gastrointestinal stromal tumors have not been evaluated. In the present study, we examined the PDCD4 expression in a total of 63 gastrointestinal stromal tumor samples at both mRNA and protein levels by RT-PCR, western blot, and immunohistochemistry. We demonstrated that the expression of PDCD4 mRNA was diminished in 68% (17/25) of the tumor samples, and the level of PDCD4 protein appeared to be decreased in 66.7% (42/63) of the samples, as compared to adjacent normal gastrointestinal tissues, which expressed high levels of PDCD4 mRNA and protein. In addition, altered expression of PDCD4 was associated with clinicopathological parameters including risk group, tumor size, and mitosis. Moreover, PDCD4 expression had a negative correlation with the Ki-67 labeling index (r = -0.6059, P < 0.0001). All these results suggest that downregulation of PDCD4 expression may have an essential role in the progression and malignant proliferation of human gastrointestinal stromal tumors.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21850542     DOI: 10.1007/s12032-011-0042-6

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  33 in total

1.  Novel human PDCD4 (H731) gene expressed in proliferative cells is expressed in the small duct epithelial cells of the breast as revealed by an anti-H731 antibody.

Authors:  H Yoshinaga; S Matsuhashi; C Fujiyama; Z Masaki
Journal:  Pathol Int       Date:  1999-12       Impact factor: 2.534

Review 2.  [Gastrointestinal stromal tumors (GIST)--a paradigm of successful targeted therapy of solid tumors].

Authors:  Borislav Belev; Damir Vrbanec; Marko Kralik; Stjepko Plestina; Branka Petricević; Maja Sirotković-Skerlev
Journal:  Acta Med Croatica       Date:  2006-12

3.  Differentially expressed protein Pdcd4 inhibits tumor promoter-induced neoplastic transformation.

Authors:  J L Cmarik; H Min; G Hegamyer; S Zhan; M Kulesz-Martin; H Yoshinaga; S Matsuhashi; N H Colburn
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

4.  Frequent loss of PDCD4 expression in human glioma: possible role in the tumorigenesis of glioma.

Authors:  Fei Gao; Pin Zhang; Chuixian Zhou; Jianfeng Li; Qun Wang; Faliang Zhu; Chunhong Ma; Wensheng Sun; Lining Zhang
Journal:  Oncol Rep       Date:  2007-01       Impact factor: 3.906

5.  Epidermal expression of the translation inhibitor programmed cell death 4 suppresses tumorigenesis.

Authors:  Aaron P Jansen; Corinne E Camalier; Nancy H Colburn
Journal:  Cancer Res       Date:  2005-07-15       Impact factor: 12.701

6.  Differentially expressed cDNAs in PLCbeta3-induced tumor suppression in a human endocrine pancreatic tumor cell line: activation of the human mismatch repair protein 3 gene.

Authors:  P Stålberg; J R Lopez-Egido; S Wang; A Gobl; K Oberg; B Skogseid
Journal:  Biochem Biophys Res Commun       Date:  2001-02-16       Impact factor: 3.575

7.  Pdcd4 inhibits growth of tumor cells by suppression of carbonic anhydrase type II.

Authors:  B Lankat-Buttgereit; C Gregel; A Knolle; A Hasilik; R Arnold; R Göke
Journal:  Mol Cell Endocrinol       Date:  2004-02-12       Impact factor: 4.102

Review 8.  Programmed cell death protein 4 (PDCD4) acts as a tumor suppressor in neuroendocrine tumor cells.

Authors:  Rüdiger Göke; Cornelia Gregel; Alexandra Göke; Rudolf Arnold; Harald Schmidt; Brigitte Lankat-Buttgereit
Journal:  Ann N Y Acad Sci       Date:  2004-04       Impact factor: 5.691

9.  Induction of PDCD4 tumor suppressor gene expression by RAR agonists, antiestrogen and HER-2/neu antagonist in breast cancer cells. Evidence for a role in apoptosis.

Authors:  Olubunmi Afonja; Dominique Juste; Sharmistha Das; Sachiko Matsuhashi; Herbert H Samuels
Journal:  Oncogene       Date:  2004-10-21       Impact factor: 9.867

10.  PDCD4 gene silencing in gliomas is associated with 5'CpG island methylation and unfavourable prognosis.

Authors:  Fei Gao; Xiaoyan Wang; Faliang Zhu; Qun Wang; Xia Zhang; Chun Guo; Chengjun Zhou; Chunhong Ma; Wensheng Sun; Yun Zhang; Youhai H Chen; Lining Zhang
Journal:  J Cell Mol Med       Date:  2009-10       Impact factor: 5.310

View more
  7 in total

1.  Clinical significance of programmed cell death 4 expression in malignant progression of human nasal inverted papillomas.

Authors:  Yan Wang; Lingling Ding; Xia Zhang; Miaoqing Zhao; Zhonghua Qu; Shanying Huang; Yun Zhang; Yanzhong Li; Fei Gao
Journal:  Med Oncol       Date:  2012-02-23       Impact factor: 3.064

Review 2.  The Role and Interactions of Programmed Cell Death 4 and its Regulation by microRNA in Transformed Cells of the Gastrointestinal Tract.

Authors:  William Frank Ferris
Journal:  Front Oncol       Date:  2022-06-29       Impact factor: 5.738

3.  Prognostic significance of PDCD4 expression in human salivary adenoid cystic carcinoma.

Authors:  Cheng Qi; Yi Shao; Ning Li; Chunyan Zhang; Miaoqing Zhao; Fei Gao
Journal:  Med Oncol       Date:  2013-02-07       Impact factor: 3.064

4.  The clinical association of programmed cell death protein 4 (PDCD4) with solid tumors and its prognostic significance: a meta-analysis.

Authors:  John Zeng Hong Li; Wei Gao; Wai-Kuen Ho; Wen Bin Lei; William Ignace Wei; Jimmy Yu-Wai Chan; Thian-Sze Wong
Journal:  Chin J Cancer       Date:  2016-11-16

5.  Increased Neutrophil Extracellular Trap Formation in Uremia Is Associated with Chronic Inflammation and Prevalent Coronary Artery Disease.

Authors:  Jwa-Kyung Kim; Chang-Won Hong; Mi Jin Park; Young Rim Song; Hyung Jik Kim; Sung Gyun Kim
Journal:  J Immunol Res       Date:  2017-03-27       Impact factor: 4.818

6.  Clinical significance of decreased programmed cell death 4 expression in patients with giant cell tumors of the bone.

Authors:  Fei Gao; Wei Zhang; Lingling Ding; Miaoqing Zhao; Zhe Ma; Shanying Huang
Journal:  Oncol Lett       Date:  2018-07-05       Impact factor: 2.967

7.  Combined Inhibition of AKT and KIT Restores Expression of Programmed Cell Death 4 (PDCD4) in Gastrointestinal Stromal Tumor.

Authors:  Marya Kozinova; Shalina Joshi; Shuai Ye; Martin G Belinsky; Dinara Sharipova; Jeffrey M Farma; Sanjay S Reddy; Samuel Litwin; Karthik Devarajan; Alex Rosa Campos; Yi Yu; Brian Schwartz; Margaret von Mehren; Lori Rink
Journal:  Cancers (Basel)       Date:  2021-07-23       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.